dc.contributor.author | Downey, C. L. | |
dc.contributor.author | Simpkins, S. A. | |
dc.contributor.author | White, J. | |
dc.contributor.author | Holliday, D. L. | |
dc.contributor.author | Jones, J. L. | |
dc.contributor.author | Jordan, L. B. | |
dc.contributor.author | Kulka, J. | |
dc.contributor.author | Pollock, S. | |
dc.contributor.author | Rajan, S. S. | |
dc.contributor.author | Thygesen, H. H. | |
dc.contributor.author | Hanby, A. M. | |
dc.contributor.author | Speirs, V | |
dc.date.accessioned | 2018-07-26T23:02:40Z | |
dc.date.available | 2018-07-26T23:02:40Z | |
dc.date.issued | 2014-04-01 | |
dc.identifier.citation | Downey , C L , Simpkins , S A , White , J , Holliday , D L , Jones , J L , Jordan , L B , Kulka , J , Pollock , S , Rajan , S S , Thygesen , H H , Hanby , A M & Speirs , V 2014 , ' The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer ' , British Journal of Cancer , vol. 110 , no. 7 , pp. 1744-1747 . https://doi.org/10.1038/bjc.2014.69 | en |
dc.identifier.issn | 0007-0920 | |
dc.identifier.other | PURE: 129547735 | |
dc.identifier.other | PURE UUID: beed91a7-6b36-44f2-b93b-40a1f2939d72 | |
dc.identifier.other | PubMed: 24548861 | |
dc.identifier.other | PubMedCentral: PMC3974086 | |
dc.identifier.other | Scopus: 84897570019 | |
dc.identifier.other | ORCID: /0000-0002-0602-4666/work/72631252 | |
dc.identifier.uri | http://hdl.handle.net/2164/10812 | |
dc.description | We are grateful to Breast Cancer Campaign for funding our collection of male breast carcinomas and for supporting DLH and SP. SAS was funded by the Wolfson Foundation and a Wellcome Trust Vacation Scholarship. HHT was funded by Cancer Research UK. We convey special thanks to members of the Leeds Breast Team for input and support at various stages of this project. | en |
dc.format.extent | 4 | |
dc.language.iso | eng | |
dc.relation.ispartof | British Journal of Cancer | en |
dc.rights | From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | breast cancer | en |
dc.subject | male | en |
dc.subject | stroma | en |
dc.subject | tumour-stroma ratio | en |
dc.subject | prognosis | en |
dc.subject | RC0254 Neoplasms. Tumors. Oncology (including Cancer) | en |
dc.subject | Wellcome Trust | en |
dc.subject | Cancer Research UK | en |
dc.subject.lcc | RC0254 | en |
dc.title | The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
dc.contributor.institution | University of Aberdeen.Institute of Medical Sciences | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Publisher PDF | en |
dc.identifier.doi | https://doi.org/10.1038/bjc.2014.69 | |